Arvee Laboratories (India) Limited (ARVEE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Arvee Laboratories (India) Limited (ARVEE) has a cash flow conversion efficiency ratio of 0.043x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.56 Million ≈ $146.61K USD) by net assets (Rs314.41 Million ≈ $3.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Arvee Laboratories (India) Limited - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Arvee Laboratories (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ARVEE total debt and obligations for a breakdown of total debt and financial obligations.
Arvee Laboratories (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Arvee Laboratories (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Khadim India Limited
NSE:KHADIM
|
0.004x |
|
Euroconsultants SA
AT:EUROC
|
0.077x |
|
Hifab Group AB Series B
ST:HIFA-B
|
0.027x |
|
Energoaparatura S.A.
WAR:ENP
|
0.353x |
|
Clean Seas Seafood Ltd
AU:CSS
|
0.194x |
|
OCB Bhd
KLSE:5533
|
0.103x |
|
Devonian Health Group Inc
V:GSD
|
-0.245x |
|
A Dong Paint JSC
VN:ADP
|
N/A |
Annual Cash Flow Conversion Efficiency for Arvee Laboratories (India) Limited (2013–2025)
The table below shows the annual cash flow conversion efficiency of Arvee Laboratories (India) Limited from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Arvee Laboratories (India) Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs312.61 Million ≈ $3.38 Million |
Rs1.19 Million ≈ $12.86K |
0.004x | -96.98% |
| 2024-03-31 | Rs291.14 Million ≈ $3.15 Million |
Rs36.64 Million ≈ $396.20K |
0.126x | +20.56% |
| 2023-03-31 | Rs280.62 Million ≈ $3.03 Million |
Rs29.29 Million ≈ $316.75K |
0.104x | +266.76% |
| 2022-03-31 | Rs239.42 Million ≈ $2.59 Million |
Rs6.81 Million ≈ $73.68K |
0.028x | -64.33% |
| 2021-03-31 | Rs214.38 Million ≈ $2.32 Million |
Rs17.11 Million ≈ $184.99K |
0.080x | -85.57% |
| 2020-03-31 | Rs186.89 Million ≈ $2.02 Million |
Rs103.34 Million ≈ $1.12 Million |
0.553x | -3.74% |
| 2019-03-31 | Rs164.62 Million ≈ $1.78 Million |
Rs94.56 Million ≈ $1.02 Million |
0.574x | +35.56% |
| 2018-03-31 | Rs141.99 Million ≈ $1.54 Million |
Rs60.16 Million ≈ $650.63K |
0.424x | -44.76% |
| 2017-03-31 | Rs41.94 Million ≈ $453.55K |
Rs32.17 Million ≈ $347.88K |
0.767x | -67.47% |
| 2016-03-31 | Rs26.41 Million ≈ $285.60K |
Rs62.26 Million ≈ $673.36K |
2.358x | -61.19% |
| 2015-03-31 | Rs14.15 Million ≈ $153.01K |
Rs85.94 Million ≈ $929.39K |
6.074x | +6203.72% |
| 2014-03-31 | Rs30.62 Million ≈ $331.12K |
Rs-3.05 Million ≈ $-32.95K |
-0.100x | -100.24% |
| 2013-03-31 | Rs930.00K ≈ $10.06K |
Rs38.55 Million ≈ $416.93K |
41.454x | -- |
About Arvee Laboratories (India) Limited
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroi… Read more